Clearbridge Investments, LLC Vertex Pharmaceuticals Inc Transaction History

Clearbridge Investments, LLC

  • $119 Billion
  • Q4 2024

A detailed history of Clearbridge Investments, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Clearbridge Investments, LLC holds 1,850,858 shares of VRTX stock, worth $951 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
1,850,858
Previous 1,972,055 6.15%
Holding current value
$951 Million
Previous $917 Million 18.73%
% of portfolio
0.63%
Previous 0.75%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$396.64 - $516.74 $48.1 Million - $62.6 Million
-121,197 Reduced 6.15%
1,850,858 $745 Million
Q3 2024

Nov 12, 2024
SELL
$460.0 - $505.78 $54.6 Million - $60 Million
-118,649 Reduced 5.68%
1,972,055 $917 Million
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $133 Million - $164 Million
-337,751 Reduced 13.91%
2,090,704 $980 Million
Q1 2024

May 13, 2024
SELL
$407.69 - $446.08 $66.9 Million - $73.2 Million
-164,120 Reduced 6.33%
2,428,455 $1.02 Billion
Q4 2023

Feb 09, 2024
SELL
$343.0 - $410.68 $120 Million - $144 Million
-350,609 Reduced 11.91%
2,592,575 $1.05 Billion
Q3 2023

Nov 13, 2023
SELL
$338.18 - $362.46 $70.4 Million - $75.5 Million
-208,238 Reduced 6.61%
2,943,184 $1.02 Billion
Q2 2023

Aug 11, 2023
SELL
$314.42 - $351.91 $58.6 Million - $65.6 Million
-186,319 Reduced 5.58%
3,151,422 $1.11 Billion
Q1 2023

May 12, 2023
SELL
$283.23 - $323.1 $42 Million - $47.9 Million
-148,379 Reduced 4.26%
3,337,741 $1.05 Billion
Q4 2022

Feb 10, 2023
SELL
$285.76 - $321.48 $119 Million - $133 Million
-414,736 Reduced 10.63%
3,486,120 $1.01 Billion
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $93.8 Million - $105 Million
-342,408 Reduced 8.07%
3,900,856 $1.13 Billion
Q2 2022

Aug 11, 2022
SELL
$234.96 - $292.55 $214 Million - $266 Million
-909,488 Reduced 17.65%
4,243,264 $1.2 Billion
Q1 2022

May 13, 2022
SELL
$221.42 - $260.97 $9.74 Million - $11.5 Million
-43,978 Reduced 0.85%
5,152,752 $1.34 Billion
Q4 2021

Feb 11, 2022
BUY
$177.01 - $223.45 $14.9 Million - $18.8 Million
84,326 Added 1.65%
5,196,730 $1.14 Billion
Q3 2021

Nov 12, 2021
BUY
$181.39 - $202.99 $23.5 Million - $26.4 Million
129,810 Added 2.61%
5,112,404 $927 Million
Q2 2021

Aug 13, 2021
SELL
$187.49 - $221.1 $101 Million - $119 Million
-538,616 Reduced 9.76%
4,982,594 $1 Billion
Q1 2021

May 13, 2021
BUY
$207.02 - $241.31 $258 Million - $300 Million
1,244,784 Added 29.11%
5,521,210 $1.19 Billion
Q4 2020

Feb 10, 2021
SELL
$207.01 - $276.09 $40.3 Million - $53.8 Million
-194,854 Reduced 4.36%
4,276,426 $1.01 Billion
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $77.8 Million - $92.2 Million
304,248 Added 7.3%
4,471,280 $1.22 Billion
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $73.5 Million - $96.4 Million
325,938 Added 8.49%
4,167,032 $1.21 Billion
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $56.7 Million - $70.3 Million
-283,619 Reduced 6.88%
3,841,094 $914 Million
Q4 2019

Feb 14, 2020
SELL
$166.71 - $223.91 $149 Million - $200 Million
-891,172 Reduced 17.77%
4,124,713 $905 Million
Q3 2019

Nov 14, 2019
SELL
$166.23 - $187.09 $26.9 Million - $30.3 Million
-161,981 Reduced 3.13%
5,015,885 $850 Million
Q2 2019

Aug 14, 2019
SELL
$164.61 - $190.37 $22.5 Million - $26.1 Million
-136,839 Reduced 2.57%
5,177,866 $0
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $27.6 Million - $32.8 Million
-168,447 Reduced 3.07%
5,314,705 $978 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $9.54 Million - $12.1 Million
-62,814 Reduced 1.13%
5,483,152 $909 Million
Q3 2018

Nov 14, 2018
SELL
$167.73 - $192.74 $76.2 Million - $87.6 Million
-454,501 Reduced 7.57%
5,545,966 $1.07 Billion
Q2 2018

Aug 14, 2018
SELL
$145.72 - $169.96 $56.9 Million - $66.3 Million
-390,259 Reduced 6.11%
6,000,467 $1.02 Billion
Q1 2018

May 15, 2018
SELL
$151.6 - $177.13 $44.7 Million - $52.2 Million
-294,943 Reduced 4.41%
6,390,726 $1.04 Billion
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $54.2 Million - $61.4 Million
-394,502 Reduced 5.57%
6,685,669 $1 Billion
Q3 2017

Nov 14, 2017
SELL
$148.13 - $162.24 $124 Million - $136 Million
-838,582 Reduced 10.59%
7,080,171 $1.08 Billion
Q2 2017

Aug 14, 2017
BUY
N/A
7,918,753
7,918,753 $1.02 Billion

Others Institutions Holding VRTX

# of Institutions
1,764
Shares Held
228M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $132B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email